These results demonstrated that virally delivered PRDX3 not only reduced the oxidative stress in non-transgenic cells upon stress and also cells carrying an ALS-causing SOD1 mutation, but furthermore, it protected cells from oxidative stress–mediated cell death. Here, SOD1 is linked to amyotrophic lateral sclerosis.